Impact of a Digital Health Respiratory Disease Management Platform on Adult Asthma

Meta Analysis of Variables Affecting Nasal Spray Product Actuation Force Profile

Development of Albuterol Sulfate pMDI using a Low Global Warming Potential Propellant 1,3,3,3-Tetrafluoropropene (HFO-1234ze) to Match Ventolin^® HFA Inhaler: I. Formulation, Container Closure System and Actuator Selection Considerations

Mapping the Product Design Space: Understanding and Controlling Manufacturing Variability in Pressurized Metered Dose Inhalers

Development of Albuterol Sulfate pMDI Using a Low Global Warming Potential Propellant 1,3,3,3-Tetrafluoropropene (HFO-1234ze) to Match Ventolin^® HFA Inhaler: II. Human Factors Engineering Considerations

High Delivered Dose in a Single Inhalation for Carrier-Based Formulations by Retaining Carrier-Fraction in Dry Powder Inhaler Blister

Further Exploration on the Manufacturing Repeatability and the Interaction Between Blending Parameters of Dry Powder Blends Produced by Resonant Acoustic Mixing

Formulation Study on siRNA-LNP Embedded in an Inhalable Freeze-Dried Matrix for Lung Targeting

Impact of Lactose Carrier Morphology and Amorphicity on the Aerosol Performance of Fluticasone Propionate Dry Powder Inhalers

Poly (ADP-Ribose) Polymerase Inhibition as a Treatment Option for Pulmonary Fibrosis

Validation of Lung Deposition of Fluticasone Propionate/Formoterol Fumarate in Chronic Obstructive Pulmonary Disease Patients Using Functional Respiratory Imaging

From Healthy to Diseased: Evaluating Bioequivalence in Orally Inhaled Drug Delivery

Sensitivity Analysis of Inhaled Drug Deposition Delivered via Metered Dose Inhalers in Chronic Obstructive Pulmonary Disease Patients

Impact of Anatomical Variability on Nasal Deposition in Pediatric Subjects of the Same Age and Gender

Investigation of In Vitro Techniques for Evaluating Ipratropium Bromide Formulations

Performance Comparison of Beclomethasone, Formoterol, and Glycopyrronium Solution Formulations in HFO-1234ze(E) to Reference Listed Drugs

Characterization Study of Nasal Deposition Targeting the Central Nervous System

Distinct Baseline Phenotypical and Functional Properties of Macrophages Derived from Two Different Lots of THP-1 Monocytes for Screening the Effects of Inhalable Drugs

Advancing High-Dosage Dry Powder Inhaler Formulations: Integrating Quality by Design for Optimized Performance

Optimizing Inhalation of a Monoclonal Antibody: Transitioning from Nebulization to a Dry Powder Inhaler

Aerosolization of Wegovy^® and Prototype Formulations of Semaglutide with the MRX004 Soft Mist Inhaler

Preliminary Development of a Nanostructured Nasal Powder for Nose-to-Brain Delivery of a Neuro-Active Steroid

Optimization of Carrier Particle Geometry for Enhanced Inhalation Performance by Parametric Design

Understanding Drug Deposition in USP and OPC_M Throats for HFA-152a Solution pMDIs

An Evaluation of Extractable Levels from Various Polybutylene Terephthalate Suppliers in the Presence of Ethanol in Formulations Containing HFA-152a and HFO-1234ze

Enhancing the Efficiency of pMDIs Through an Innovative Mesh Grid Design

Selection of the Best Capsule Type to Maximize the Performance of a Model Carrier-Based Dry Powder Inhalation Formulation

Fine-Tuning Spray-Dried Inhalable Powders: Impact of Component Saturation on Performance

Spray-Dried Lipid Nanoparticles for Intranasal Delivery

Inhalable Spray-Dried Lipid Nanoparticles for Pulmonary siRNA Delivery

The Role of Carrier Particle Size in Adhesive Mixtures for Inhalation

Predicting Blend Performance of a Dry Powder Inhalation Formulation Using Raman Spectroscopy

Experimental Investigation of the Air and Droplet Dynamics of a Soft Mist Inhaler

Ultrasonically Actuated Platform Integrating a Drug-Loaded Cartridge with Microfluidics: Delivering High-Viscosity Solutions with Adjustable Flow Rates

Assessment of the Semi-Automatic Filling of UDS-P Device with Engineered Powders for Nasal Delivery

The Impact of Excipients and Spray Drying on Improving the Permeability of Spray-Dried Leuprolide Formulations Using RPMI-2650 Cells

The Impact of Orbital^TM Device Puck Configurations on the Deposition of Itraconazole 

A New Nebulizer Architecture Using Coupling Layer-free Superstrates Allows Easier Cleaning and Better Performance Over Time

An Acoustic Nebulizer Platform for Aerosolization of Biologics

Novel Method for Sized Aerosol Sampling in the Characterization of Nebulized Biologics

An Assessment of the Potential Manufacturing Scale Flammability of Low Global Warming Potential Formulations

Assessment of Suspension Characteristics of Budesonide Micronized by Traditional Jet Milling and by Sonocrystallization Suspended in High and Low Global Warming Propellants

Novel Spray-Dried Nasal Powder of Eletriptan: In Vitro and Pre-Clinical In Vivo Studies

Plume Temperature: HFA-134a & HFA-227ea Compared to Low GWP Propellants HFA-152a & HFO-1234ze

Correlation of Leakage and Aerosol Performance Measurement for Five Valved Holding Chambers with Pediatric Facemasks

Simplified Mechanism Modelling: Optimizing a Dry Powder Inhaler for Ease of Use

The Importance of Shear Thinning for High Viscosity Nasal Suspensions

Advancing Cleaning and Disinfection Standards for Mesh Nebulizers: A Patient-Centric Study Introducing Zerowater®

The Influence of Freezing, Storage, and Formulation on Mannitol Polymorphism and Powder Deposition after Spray Freeze-Drying

Spray Freeze-Drying Inhalable Powders of a Monoclonal Antibody: The Role of Formulation in Achieving Stability and Flowability

Modelling the Impact of Mucoadhesive Formulations on Intranasal Delivery of RIG-101, a Stem-Loop Ribonucleic Acid Therapeutic

Refining Regional Deposition Predictions in Metered Dose Inhalers: A Comparison of Static and Dynamic ICRP Models

Evaluating Critical Handling Errors in Inhalation Devices: The Role of Tailored In Vitro Testing

Development of a Particle Engineered Aspirin Powder for Intranasal Delivery: Evaluating Delivery Performance from a Novel Intranasal Device

Clinical Evaluation of a Prototype Smart Valved Holding Chamber to Monitor and Improve Adherence to Metered Dose Inhaler Medication

Inhaled Maintenance and Reliever Therapy and Anti-Inflammatory-Reliever Therapy: Exploring In Vitro Performance of a Portable Valved Holding Chamber

Assessing Fitness-for-Purpose to Support Clinical Application of an Adaptive Breath-Actuated Nebulizer

Development of a Single Actuation Impaction Method for Aerosolization Assessment of Soft Mist Inhalers: Comparison for MRX004 and Respimat^®

Pre-Actuation Microstructure within Dry Powder Inhaler Blisters Revealed Through X-Ray Computed Tomography

Influence of Viscosity and Surface Tension on Droplet Size Distribution and Plume Characteristics of the Respimat® Soft Mist Inhaler

Development of a Dry Powder Formulation of Deoxyribonuclease I using Spray Drying

Bulk Excipient Screening of a Spray Dried Glucagon-Like Peptide 1 Receptor Agonist Formulation

Leveraging Chemo-Immunotherapy to Remodel the Tumor Microenvironment and Enhance Treatment Efficacy in Osteosarcoma Lung Metastases

In Vivo Deposition and Retention of Ciprofloxacin Liposomal Dry Powder Aerosol

Evaluation of the Resyca® PFSI™ Soft Mist Inhaler for Efficient Delivery of mRNA-lipid Nanoparticles to the Lungs

Comparison of Solution and Suspension Nasal Spray Formulations by Laser Diffraction and Next Generation Impactor Methods